Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects (original) (raw)

International Journal of Obesity volume 21, pages 972–979 (1997)Cite this article

Abstract

OBJECTIVE: The action of noradrenaline on human mesenteric, omental and subcutaneous adipocytes was compared. We also determined whether regional differences in the noradrenaline-effect were linked to variations in adrenoceptor subtype function. DESIGN: The lipolytic effects of different concentrations of noradrenaline (β1-, β2-, β3- and α2-adrenoceptor agonist), isoprenaline (β1-, β2- and β3-adrenoceptor agonist) and selective β1-, β2- and β3-adrenoceptor agonists (dobutamine, terbutaline and CGP 12177, respectively) were studied in adipocytes isolated from the three adipose tissue regions in the same subject. In addition, the effect of the α2-adrenoceptor antagonist, yohimbine, was studied on noradrenaline-induced glycerol release. SUBJECTS: Thirteen otherwise healthy obese subjects (nine females, four males). RESULTS: The noradrenaline-induced lipolytic response did not differ between omental and mesenteric adipocytes but was 50% higher than in subcutaneous adipocytes (P<0.05). Furthermore, noradrenaline sensitivity and intrinsic activity (in relation to isoprenaline) were higher in the two visceral fat cells than in the subcutaneous fat cells. The intrinsic activity of noradrenaline increased close to that of isoprenaline when yohimbine was added to the incubation system. Isoprenaline sensitivity was five times higher in the two visceral fat cells than in the subcutaneous fat cells. For CGP 12177, sensitivity and intrinsic activity did not differ between mesenteric and omental adipocytes, but was higher in these two regions when compared to subcutaneous adipocytes. For dobutamine and terbutaline no significant regional differences were found. CONCLUSION: β3-adrenoceptor action is enhanced and α2-adrenoceptor action is decreased in both mesenteric and omental adipocytes as compared to subcutaneous adipocytes. However, the two visceral fat depots show no difference in adrenoceptor function. The difference in β3- and α2-adrenoceptor function might explain why noradrenaline induced lipolysis is increased in the two visceral fat depots, as compared to the subcutaneous fat depot.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Medicine, Research Center, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden
    V Van Harmelen, F Lönnqvist, V Large, S Reynisdottir & P Arner
  2. Department of Surgery, Research Center, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden
    A Thörne & A Wennlund

Authors

  1. V Van Harmelen
    You can also search for this author inPubMed Google Scholar
  2. F Lönnqvist
    You can also search for this author inPubMed Google Scholar
  3. A Thörne
    You can also search for this author inPubMed Google Scholar
  4. A Wennlund
    You can also search for this author inPubMed Google Scholar
  5. V Large
    You can also search for this author inPubMed Google Scholar
  6. S Reynisdottir
    You can also search for this author inPubMed Google Scholar
  7. P Arner
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Van Harmelen, V., Lönnqvist, F., Thörne, A. et al. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.Int J Obes 21, 972–979 (1997). https://doi.org/10.1038/sj.ijo.0800504

Download citation

Keywords

This article is cited by